Emmaus Life Sciences (EMMA) Short Interest Ratio & Short Volume $0.01 +0.00 (+2.94%) As of 08/7/2025 01:36 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Emmaus Life Sciences Short Interest DataEmmaus Life Sciences (EMMA) has a short interest of 18,800 shares. This marks a 42.42% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.9, indicating that it would take 1.9 days of the average trading volume of 7,344 shares to cover all short positions.Current Short Interest18,800 sharesPrevious Short Interest13,200 sharesChange Vs. Previous Month+42.42%Dollar Volume Sold Short$265.08Short Interest Ratio1.9 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares63,870,000 sharesPercentage of Shares Shorted0.03%Today's Trading Volume28,025 sharesAverage Trading Volume7,344 sharesToday's Volume Vs. Average382% Short Selling Emmaus Life Sciences? Sign up to receive the latest short interest report for Emmaus Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEMMA Short Interest Over TimeEMMA Days to Cover Over TimeEMMA Percentage of Float Shorted Over Time Emmaus Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202518,800 shares $265.08 +42.4%N/A1.9 $0.01 6/30/202513,200 shares $171.60 -60.2%0.0%0.1 $0.01 6/15/202533,200 shares $564.40 +4,642.9%0.1%9.2 $0.02 5/31/2025700 shares $13.93 No Change0.0%0 $0.02 5/15/2025700 shares $8.40 -50.0%0.0%0 $0.01 4/30/20251,400 shares $23.10 -75.0%N/A0.4 $0.02 4/15/20255,600 shares $89.60 +16.7%0.0%0.7 $0.02 3/31/20254,800 shares $82.08 -25.0%0.0%0.2 $0.02 3/15/20256,400 shares $175.36 +30.6%0.0%0.1 $0.03 2/28/20254,900 shares $85.75 -51.5%0.0%0 $0.02 Get the Latest News and Ratings for EMMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Emmaus Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 2/15/202510,100 shares $451.47 -53.5%0.0%0.1 $0.04 1/31/202521,700 shares $353.71 +47.6%N/A1.1 $0.02 1/15/202514,700 shares $205.80 +2,000.0%N/A0.6 $0.01 12/31/2024700 shares $5.95 No ChangeN/A0 $0.01 12/15/2024700 shares $4.69 -22.2%N/A0 $0.01 11/30/2024900 shares $26.91 -10.0%N/A0 $0.03 11/15/20241,000 shares $36.50 +42.9%N/A0 $0.04 10/31/2024700 shares $24.50 No ChangeN/A0 $0.04 10/15/2024700 shares $24.50 No ChangeN/A0 $0.04 9/30/2024700 shares $20.86 No ChangeN/A0 $0.03 9/15/2024700 shares $26.25 No ChangeN/A0 $0.04 8/31/2024700 shares $0.21 No ChangeN/A1 $0.00 8/15/2024700 shares $2.10 No ChangeN/A0 $0.00 7/31/2024700 shares $1.75 No ChangeN/A0.1 $0.00 7/15/2024700 shares $49.91 No ChangeN/A0 $0.07 6/30/2024700 shares $70.70 No ChangeN/A0 $0.10 6/15/2024700 shares $64.01 No ChangeN/A0.1 $0.09 5/31/2024700 shares $64.40 No ChangeN/A0.1 $0.09 5/15/2024700 shares $72.10 No ChangeN/A0.3 $0.10 4/30/2024700 shares $70.00 No ChangeN/A0.1 $0.10 4/15/2024700 shares $73.50 -12.5%N/A0.9 $0.11 3/31/2024800 shares $84.00 -89.5%N/A0.1 $0.11 3/15/20247,600 shares $768.36 +33.3%N/A0.4 $0.10 2/29/20245,700 shares $676.02 +714.3%N/A0.1 $0.12 2/15/2024700 shares $67.27 -93.6%N/A0.1 $0.10 1/15/20244,100 shares $369.00 -6.8%N/A0.4 $0.09 12/31/20234,400 shares $440.33 +450.0%N/A0 $0.10 12/15/2023800 shares $88.00 -50.0%N/A0.1 $0.11 11/30/20231,600 shares $208.00 +128.6%N/A0 $0.13 11/15/2023700 shares $77.00 No ChangeN/A0 $0.11GENIUS Act: Cancel Your Money? (Ad)A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.Get the free info kit with 3 strategies to sidestep digital dollar control. 10/31/2023700 shares $84.00 No ChangeN/A0 $0.12 10/15/2023700 shares $105.00 -22.2%N/A0 $0.15 9/30/2023900 shares $112.50 No ChangeN/A0.5 $0.13 9/15/2023900 shares $117.00 +28.6%N/A0.1 $0.13 8/31/2023700 shares $105.88 -41.7%N/A0 $0.15 8/15/20231,200 shares $252.00 No ChangeN/A0.4 $0.21 7/31/20231,200 shares $264.00 +71.4%N/A0.2 $0.22 7/15/2023700 shares $168.35 -50.0%N/A0.1 $0.24 6/30/20231,400 shares $322.00 -68.9%N/A0.2 $0.23 6/15/20234,500 shares $1.22 thousand -65.1%N/A0.8 $0.27 5/31/202312,900 shares $4.13 thousand +1,742.9%N/A0.5 $0.32 5/15/2023700 shares $224.00 -83.7%N/A0 $0.32 4/30/20234,300 shares $1.35 thousand -4.4%N/A0.2 $0.32 4/15/20234,500 shares $1.49 thousand +50.0%N/A0.1 $0.33 3/31/20233,000 shares $907.50 +328.6%N/A0.3 $0.30 3/15/2023700 shares $245.00 No ChangeN/A0.1 $0.35 2/28/2023700 shares $266.00 -91.9%N/A0.1 $0.38 2/15/20238,600 shares $4.04 thousand +244.0%N/A0.2 $0.47 1/31/20232,500 shares $999.50 +257.1%N/A0 $0.40 1/15/2023700 shares $203.00 No ChangeN/A0 $0.29 12/30/2022700 shares $182.21 -87.7%N/A0 $0.26 12/15/20225,700 shares $1.88 thousand +714.3%N/A0.2 $0.33 11/30/2022700 shares $271.60 -86.0%N/A0 $0.39 11/15/20225,000 shares $1.50 thousand +72.4%N/A0.2 $0.30 10/31/20222,900 shares $1.31 thousand +314.3%N/A0 $0.45 10/15/2022700 shares $126.00 No ChangeN/A0 $0.18 9/30/2022700 shares $119.00 -53.3%N/A0 $0.17 9/15/20221,500 shares $450.00 No ChangeN/A0.2 $0.30 8/31/20221,500 shares $540.00 +87.5%N/A0.1 $0.36 8/15/2022800 shares $296.00 +14.3%N/A0 $0.37 7/31/2022700 shares $245.00 No ChangeN/A0 $0.35 7/15/2022700 shares $280.00 No ChangeN/A0.1 $0.40 6/30/2022700 shares $315.00 No ChangeN/A0.1 $0.45 6/15/2022700 shares $252.00 -66.7%N/A0 $0.36 5/31/20222,100 shares $840.00 -83.5%N/A0 $0.40 5/15/202212,700 shares $3.19 thousand +693.8%N/A0.2 $0.25 4/30/20221,600 shares $1.28 thousand -5.9%N/A0.2 $0.80 4/15/20221,700 shares $1.29 thousand +142.9%N/A0 $0.76 3/31/2022700 shares $700.00 -12.5%N/A0 $1.00 3/15/2022800 shares $1.09 thousand No ChangeN/A0.1 $1.36 2/28/2022800 shares $1.16 thousand -33.3%N/A0 $1.45 2/15/20221,200 shares $1.74 thousand +71.4%N/A0 $1.45 1/31/2022700 shares $980.00 -12.5%N/A0 $1.40 1/15/2022800 shares $1.15 thousand +14.3%N/A0 $1.44 12/31/2021700 shares $1.17 thousand No ChangeN/A0 $1.67 12/15/2021700 shares $1.07 thousand -50.0%N/A0 $1.53 11/30/20211,400 shares $3.01 thousand -57.6%N/A0 $2.15 11/15/20213,300 shares $4.03 thousand +230.0%N/A0.1 $1.22 10/29/20211,000 shares $1.43 thousand -23.1%N/A0.1 $1.43 10/15/20211,300 shares $2.11 thousand No ChangeN/A0.1 $1.62GENIUS Act: Cancel Your Money? (Ad)A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. Backed by the government but powered by private corporations, this initiative paves the way for digital dollars—programmable, trackable, and outside your control. Once embedded into apps, banks, and retail systems, opting out may no longer be possible. But there’s still time to protect your financial freedom—if you act before the system goes fully live.Get the free info kit with 3 strategies to sidestep digital dollar control. 9/30/20211,300 shares $2.08 thousand +44.4%N/A0.1 $1.60 9/15/2021900 shares $1.30 thousand -79.6%N/A0 $1.44 8/31/20214,400 shares $6.82 thousand +46.7%N/A0.3 $1.55 8/13/20213,000 shares $4.65 thousand -37.5%N/A0.3 $1.55 7/30/20214,800 shares $7.20 thousand +433.3%N/A0.4 $1.50 7/15/2021900 shares $1.35 thousand No ChangeN/A0.1 $1.50 6/30/2021900 shares $1.28 thousand -70.0%N/A0.1 $1.42 6/15/20213,000 shares $4.80 thousand +150.0%N/A0.3 $1.60 5/28/20211,200 shares $1.94 thousand +33.3%N/A0.2 $1.62 5/14/2021900 shares $1.31 thousand -74.3%N/A0 $1.45 4/30/20213,500 shares $4.52 thousand +288.9%N/A0.1 $1.29 4/15/2021900 shares $1.22 thousand +28.6%N/A0.1 $1.35 3/31/2021700 shares $1.20 thousand No ChangeN/A0 $1.71 3/15/2021700 shares $1.05 thousand -50.0%N/A0 $1.50 2/26/20211,400 shares $1.97 thousand -33.3%N/A0 $1.41 2/12/20212,100 shares $3.51 thousand -12.5%N/A0 $1.67 1/29/20212,400 shares $2.93 thousand -11.1%N/A0.8 $1.22 1/15/2021700 shares $861.00 -68.2%N/A0 $1.23 12/31/2020700 shares $805.00 No ChangeN/A0 $1.15 12/15/2020700 shares $770.00 -68.2%N/A0 $1.10 11/30/20202,200 shares $2.64 thousand -31.3%N/A0.1 $1.20 11/15/20203,200 shares $2.72 thousand +3.2%N/A0.1 $0.85 10/30/20203,100 shares $2.54 thousand -75.2%N/A0.2 $0.82 10/15/202012,500 shares $9.40 thousand +468.2%N/A0.3 $0.75 9/30/20202,200 shares $2.13 thousand +144.4%N/A0.1 $0.97 9/15/2020900 shares $1.04 thousand -40.0%N/A0 $1.16 EMMA Short Interest - Frequently Asked Questions What is Emmaus Life Sciences' current short interest? Short interest is the volume of Emmaus Life Sciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 18,800 shares of EMMA short. Learn More on Emmaus Life Sciences' current short interest. What is a good short interest ratio for Emmaus Life Sciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EMMA shares currently have a short interest ratio of 2.0. Learn More on Emmaus Life Sciences's short interest ratio. Is Emmaus Life Sciences' short interest increasing or decreasing? Emmaus Life Sciences saw a increase in short interest in July. As of July 15th, there was short interest totaling 18,800 shares, an increase of 42.4% from the previous total of 13,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Emmaus Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Emmaus Life Sciences: NovaBay Pharmaceuticals, Inc. (0.66%), Titan Pharmaceuticals, Inc. (0.91%), Tharimmune, Inc. (0.63%), CNS Pharmaceuticals, Inc. (6.93%), Redhill Biopharma Ltd. (1.07%), SciSparc Ltd. (3.18%), Lipella Pharmaceuticals Inc. (0.06%), PMGC Holdings Inc. (17.38%), UNITY Biotechnology, Inc. (0.25%), Psyence Biomedical Ltd. (1.81%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Emmaus Life Sciences stock? Short selling EMMA is an investing strategy that aims to generate trading profit from Emmaus Life Sciences as its price is falling. EMMA shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Emmaus Life Sciences? A short squeeze for Emmaus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EMMA, which in turn drives the price of the stock up even further. How often is Emmaus Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EMMA, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies NovaBay Pharmaceuticals Short Squeeze Oasmia Pharmaceutical Short Squeeze Titan Pharmaceuticals Short Squeeze Tharimmune Short Squeeze CNS Pharmaceuticals Short Squeeze Redhill Biopharma Short Squeeze SciSparc Short Squeeze Lipella Pharmaceuticals Short Squeeze PMGC Short Squeeze UNITY Biotechnology Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:EMMA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Emmaus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Emmaus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
